1. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors. Issue 7 (July 2021) Authors: Sasada, Shinsuke; Kimura, Yuri; Masumoto, Norio; Emi, Akiko; Kadoya, Takayuki; Arihiro, Koji; Okada, Morihito Journal: European journal of surgical oncology Issue: Volume 47:Issue 7(2021) Page Start: 1588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study. Issue 4 (April 2018) Authors: Sasada, Shinsuke; Masumoto, Norio; Goda, Noriko; Kajitani, Keiko; Emi, Akiko; Kadoya, Takayuki; Okada, Morihito Journal: European journal of surgical oncology Issue: Volume 44:Issue 4(2018) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer. (October 2022) Authors: Ikejiri, Haruka; Sasada, Shinsuke; Emi, Akiko; Masumoto, Norio; Kadoya, Takayuki; Okada, Morihito Journal: Breast Issue: Volume 65(2022) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Monitoring of Programmed Cell Death Ligand-1 Blockade Using FDG PET/CT for Microsatellite Instability-High Metastatic Breast Cancer. (29th March 2022) Authors: Kawamata, Ayumi; Sasada, Shinsuke; Emi, Akiko; Masumoto, Norio; Kadoya, Takayuki Journal: Clinical nuclear medicine Issue: Volume 47:Number 3(2022) Page Start: e252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Monitoring of Programmed Cell Death Ligand-1 Blockade Using FDG PET/CT for Microsatellite Instability-High Metastatic Breast Cancer. (March 2022) Authors: Kawamata, Ayumi; Sasada, Shinsuke; Emi, Akiko; Masumoto, Norio; Kadoya, Takayuki Journal: Clinical nuclear medicine Issue: Volume 47:Number 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer. (May 2022) Authors: Kimura, Yuri; Masumoto, Norio; Kanou, Akiko; Fukui, Kayo; Sasada, Shinsuke; Emi, Akiko; Kadoya, Takayuki; Arihiro, Koji; Okada, Morihito Journal: Surgical oncology Issue: Volume 41(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗